NIR-responsive carbon monoxide nanoplatform for synergistic antibacterial and anti-inflammatory therapy of refractory keratitis and biofilm-infected wounds
Materials Today Bio · 2026-12 · 41 · 103727
DOI: 10.1016/j.mtbio.2026.103727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2026-12. Verfasst von Yuqi Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang University, Eye Center of Second Affiliated Hospital, School of Medicine, Hangzhou, 310009, China. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Drug-resistant bacterial biofilms hinder the treatment of persistent infections by limiting drug penetration and reducing bacterial susceptibility through their dense extracellular matrix and active signaling networks. Herein, we developed a near-infrared (NIR) light-responsive, bacteria-targeting nanoplatform, termed UCMSP-CL, for localized carbon monoxide (CO) delivery and biofilm eradication. UCMSP-CL disrupts biofilm architecture and adheres to bacteria through electrostatic interactions and enzyme-substrate recognition. Subsequent NIR irradiation triggers local CO release, which induces severe bacterial metabolic exhaustion by inhibiting the bacterial respiratory chain, depleting ATP and compromising membrane integrity, while exerting potent anti-inflammatory effects. In murine models of methicillin-resistant Staphylococcus aureus (MRSA) keratitis and infected skin wounds, NIR-irradiated UCMSP-CL markedly reduced bacterial burden, promoted biofilm clearance, alleviated local inflammation, and accelerated tissue repair. These findings establish a controllable platform that couples antibacterial and anti-inflammatory activities, offering a potential strategy for treating biofilm-associated and drug-resistant infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhejiang University, Eye Center of Second Affiliated Hospital, School of Medicine, Hangzhou, 310009, China.
- Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, 310009, China.
- Zhejiang Cancer Hospital, Zhejiang Key Laboratory of Functional Nucleic Acids for Basic and Clinical Application, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China.
- School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China.
Förderung
- National Key Research and Development Program of China
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Han, Y., Deng, K., Chen, R., Chen, F., Yao, K., Ye, Y., Du, Z., & Shentu, X. (2026). NIR-responsive carbon monoxide nanoplatform for synergistic antibacterial and anti-inflammatory therapy of refractory keratitis and biofilm-infected wounds. Materials Today Bio, 41, 103727. https://doi.org/10.1016/j.mtbio.2026.103727
Vancouver
Han Y, Deng K, Chen R, Chen F, Yao K, Ye Y, et al. NIR-responsive carbon monoxide nanoplatform for synergistic antibacterial and anti-inflammatory therapy of refractory keratitis and biofilm-infected wounds. Materials Today Bio. 2026;41:103727. doi:10.1016/j.mtbio.2026.103727
BibTeX
@article{Han2026,
author = {Han, Yuqi and Deng, Kai and Chen, Ruoqi and Chen, Fuyao and Yao, Ke and Ye, Yang and Du, Zhen and Shentu, Xingchao},
title = {NIR-responsive carbon monoxide nanoplatform for synergistic antibacterial and anti-inflammatory therapy of refractory keratitis and biofilm-infected wounds},
journal = {Materials Today Bio},
year = {2026},
volume = {41},
pages = {103727},
doi = {10.1016/j.mtbio.2026.103727}
}
EUVIMED